Since the role of metaflammasome proteins were highlighted in AD pathophysiology, the modulation of PKR activity could attenuate the detrimental consequences of metabolic disorders on brain signaling pathways even associated with obesity [20]. The gene discussed is EIF2AK2; the disease is Alzheimer disease.